FDA OKs Turoctocog Alfa Pegol (Esperoct) for Hemophilia A FDA OKs Turoctocog Alfa Pegol (Esperoct) for Hemophilia A

Turoctocog alfa pegol is an extended half-life factor VIII molecule for treatment and prophylaxis of bleeding episodes and perioperative management in adults and children with hemophilia A.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news